Pathogenesis of the HAART-associated metabolic syndrome.
Behrens
Georg M N
GM
Division of Clinical Immunology, Hannover Medical School, Hannover, Germany. Behrens@wehi.edu.au
Stoll
Matthias
M
Schmidt
Reinhold E
RE
D000818:Animals; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D022762:CCAAT-Enhancer-Binding Proteins / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000503:physiopathology; D008079:Lipoproteins, VLDL / Q000378:metabolism; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000503:physiopathology*; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors / Q000378:metabolism
D022762:CCAAT-Enhancer-Binding Proteins; D004268:DNA-Binding Proteins; D005230:Fatty Acids, Nonesterified; D008079:Lipoproteins, VLDL; C497387:SREBF1 protein, human; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors